Filter by: patients
Home > Community Treatment Reports and Side Effects > Carbamazepine Treatment Report
What is Carbamazepine?

Carbamazepine is an anticonvulsant used to treat partial and mixed seizure patterns, generalized tonic-clonic seizures and trigeminal neuralgia. Off label it is used to treat resistant schizophrenia, alcohol withdrawal, restless leg syndrome and post traumatic stress disorders.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Epilepsy 509 178 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Trigeminal neuralgia (trigeminal nerve pain) 69 17 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Treat my mood condition(s) 66 17 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Bipolar Disorder 43 15 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Pain 42 8 Efficacy_major Efficacy_moderate Efficacy_none Efficacy_cant_tell
Other 33 10 Efficacy_major Efficacy_moderate Efficacy_cant_tell

See all 745 patients currently taking Carbamazepine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 63
Moderate
 110
Mild
 89
None
 66

Commonly reported side effects, conditions, and hospitalizations associated with Carbamazepine

Dizziness 31
Sleepiness 16
Fatigue 16
Increased fatigue 15
Excessive daytime sleepiness (somnolence) 15
Tiredness 14
See all 190 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Carbamazepine. See all 49 dosages ►

  100 mg daily 200 mg daily 300 mg daily 400 mg daily 600 mg daily 800 mg daily 900 mg daily 1,000 mg daily 1,200 mg daily 1,600 mg daily
  38 Number of Patients: 38 95 Number of Patients: 95 38 Number of Patients: 38 142 Number of Patients: 142 112 Number of Patients: 112 130 Number of Patients: 130 14 Number of Patients: 14 40 Number of Patients: 40 82 Number of Patients: 82 19 Number of Patients: 19  

Reported Stop Reasons

Why Patients Stopped Taking Carbamazepine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 137   Side effects too severe: 37%
Did not seem to work 129   Did not seem to work: 35%
Doctor's advice 119   Doctor's advice: 32%
Other 61   Other: 16%
Course of treatment ended 18   Course of treatment ended: 5%
Personal research 14   Personal research: 4%
Expense 12   Expense: 3%
Not indicated 10   Not indicated: 3%
Change in health plan coverage 8   Change in health plan coverage: 2%

See all 347 patients who’ve stopped taking Carbamazepine

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Carbamazepine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Carbamazepine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Carbamazepine

Always
 251 77%
Usually
 55 17%
Sometimes
 11 3%
Never
 11 3%

Burden

Difficulty being on treatment

Burden of Carbamazepine

Very
 22 7%
Somewhat
 41 13%
A little
 68 21%
Not at all
 197 60%

Cost

Paid out of pocket

Cost of Carbamazepine

$200+
 4 2%
$100-199
 10 5%
$50-99
 19 9%
$25-49
 33 16%
< $25
 142 68%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.